Introducing the Only Minimally Invasive Treatment That Gets to the Root of Chronic Diabetic Foot Ulcers.
Why treat and re-treat the surface of your diabetic foot ulcer (DFU) indefinitely? Or worse, risk joining the 25% of patients that require amputation?1 Now, there’s a safe, simple, and single procedure that goes under the ulcer to remove the bony prominences that can cause and worsen wounds.
The Tenex Health TX® System is a minimally invasive solution that uses advanced ultrasonic technology for the precise removal of scar tissue and the contributing factor of recurrence, the bony prominence. The entire outpatient procedure takes just minutes under local anesthesia, uses mini incisions, and doesn’t require stitches. It’s a revolutionary, single-procedure treatment option that gives you a better chance of getting back on your feet sooner — and staying there.
A Single-Procedure Solution With Multiple Advantages
Tenex Health TX® System
- Treats the scar tissue and bony prominence below the surface of the wound
- Single treatment
- Does not enter or expand wound
- Removes scar tissue while sparing healthy soft tissue
- Skin grafts not required
- Treats the contributing factor of recurrence, the bony prominence, for a better chance of fast and lasting healing
- Decreases overall cost of care
Conventional Diabetic Foot Ulcer Treatments
- Treats only the surface of the wound
- Requires multiple office visits
- Repeat surface cleaning and debridement may expand wound area
- Skin grafts often required
- Can take months or longer to heal
- Infection rates as high as 80%2, recurrence as high as 65%3, and over 25% of patients may require amputation1
- Ongoing treatments increase cost of care
A Unique, Definitive, and Durable Solution for the Chronic Diabetic Foot Ulcer
Freed L. Diabetes 2020. Jun; 69 (Supplement 1). Diabetic foot ulcers remain a difficult to treat condition with recurrence expected, even with effective initial treatment. The author describes an innovative new treatment with an ultrasonic probe inserted around the diabetic foot ulcer, through portals into the thickened scar tissue and osseous prominence subcutaneous to the wound crater. Ultrasonic energy from the probe is used to cut and remove the scar tissue and bone, facilitating a healing response and eliminating the aggravating factor in many cases of recurrence.
105 ulcers, MW Class 1-3, were treated with this technique from Jan 2014 – Nov 2019. All ulcers were chronic, with a duration of between 3 months and over 3 years (mean = 15 months). All ulcers had been unsuccessfully treated with multiple treatment methods. Mean ulcer size was 20mm. Mean treatment time was 4.5 minutes. The ultrasonic probe was inserted through 2-4 puncture sites around each ulcer and used to cut and aspirate the thickened scar tissue, followed by the osseous prominence, beneath the ulcer. Patient follow-up was conducted weekly until healing, and thereafter at 3-month intervals.
At a mean healing time of 3.5 weeks (7 – 42 days), 101/105 or 96% of the ulcers completely healed. 5/101 or 5% of the healed ulcers subsequently recurred in 14 – 33 months. One patient developed a bacteremia and one developed a local cellulitis. Both responded to antibiotics. The treatment was shown to be relatively inexpensive and easy to learn. In conclusion, a single treatment with an ultrasonic probe provided a high rate of complete healing, with low recurrence and a low complication rate.
View the clinical study poster presentation on the American Diabetes Association website (clicking the link will take you to the ADA site).
VIDEOS
Tenex Health TX® vs. Conventional Treatment
Unlike the repeat cleaning and debridement that involves numerous visits to your doctor, Tenex Health TX® gets under the surface to treat diabetic foot ulcers in one treatment.
Tenex Health TX®
treats a root cause of recurrence
Conventional treatments
only treat the surface of the wound
Clinical Experience
Evidence shows that diabetic foot ulcer procedures using the Tenex Health TX® System are precise and highly effective at removing the bony prominence that can contribute to wound recurrence. In a retrospective case study of 105 DFU patients, all who had prior advanced wound care, 96% were healed with a less than 5% recurrence rate and an average healing time of less than 3.5 weeks.4
Speak to your doctor about Tenex Health TX®.
If you don’t have a doctor, let us help you find one.
Fill out the form to find a doctor near you.
Use of Find-A-Doctor locator terms & conditions.
You must first accept the following disclaimer before submitting a Find-A-Doctor request . Once you have accepted this disclaimer, your search results will be available.
Thank you for reading and understanding this disclaimer before accepting it:
- If you think you have an emergency, call your physician or 911 immediately.
- Please note that Tenex Health, Inc. provides this listing as a service. Tenex Health, Inc. does not have any ownership or direct financial interest in any of the specific doctors or clinics listed on our “Find a Doctor” locator. We have no vested interest in any specific physicians, nor do we provide any recommendation, assurance, or guarantee with respect to their service. The physicians listed on this site have notified Tenex Health, Inc. that they use Tenex Health, Inc. There are no other listing criteria, and Tenex Health, Inc. does not endorse, recommend or certify any of these physicians. Tenex Health makes no guarantee or assurance concerning the physician’s training, competency, qualifications, credentials, skill, our outcomes of the listed providers. What may be a good provider for some may be a poor provider for others. Information on this site should not be used as a substitute for talking with your physician. Always talk with your physician about diagnosis and treatment information.
- The information on this site as to a practitioner is provided “as is” for general information only.
- Tenex Health, Inc. does not guarantee or make any warranties, express or implied, as to the quality of medical advice or care given by any listed physician.
- Tenex Health, Inc. makes no guarantee or assurance concerning the accuracy or completeness of the listing. Tenex Health, Inc. does verify the contact information of the physician prior to initially releasing the post to the website.While Tenex Health, Inc. attempts to maintain a current list, physicians may stop using Tenex Health, Inc. products and not notify Tenex Health, Inc. Tenex Health, Inc. reserves the sole right to add or delete content without further notice.
- The names of doctors listed in the results are based solely upon the data entered by the user. If the user enters a ZIP code, the locator will display first on the list the doctor who is closest to the geographical center of the user’s ZIP code.
- Use of the “Find a Doctor” page is subject to the Tenex Health, Inc., including the Limitations of Liability.
Tenex Health’s minimally invasive technology eliminates chronic tendon and bone spur pain by precisely targeting and removing damaged tissue, without the need for conventional surgery.
Privacy Policy
Privacy Policy
This is the Tenex Health, Inc. Privacy Policy. This Privacy Policy explains how we handle and protect the non-personal information (information which cannot be used to identify you personally) and personal information that you provide to us on websites controlled by Tenex Health, Inc. Please read this Privacy Policy before using the Tenex Health, Inc. website or submitting information to us.
By using this site, you agree to the terms of this Privacy Policy. Whenever you submit information via this site, you consent to the collection, use, and disclosure of that information in accordance with this Privacy Policy.
This Privacy Policy does not apply to personal information collected from you offline or another Tenex Health, Inc. website that does not link to this Privacy Policy, to residents of countries other than the United States, or to third-party websites to which the Tenex Health, Inc. website may link. In the event this Tenex Health, Inc. website links to another website operated by a third party, please be aware that Tenex Health, Inc. does not review, control or monitor the privacy practices of these sites. The Tenex Health, Inc. Privacy Policy does not extend to the linked site. The links provided from this Tenex Health, Inc. website are for convenience only. We recommend that if you choose to access these websites, please read the privacy policies of each website and determine if you would like to continue using these websites. Your use of this site, which links to this Privacy Policy is subject to this Privacy Policy
Terms of Use
Terms of Use
Tenex Health, Inc. understands that online security is important to all the visitors of this website. The company has taken reasonable steps to protect the personal information submitted from loss, misuse, unauthorized disclosure, or alteration. While Tenex Health, Inc. values the security of personal and non-personal information, there can be no guarantee that any information submitted via the Internet is completely secure, will not be intercepted or is free from error. Information submitted electronically, such as via email or uploaded to this website may not be secure. Therefore, if you are concerned about the security of the information submitted, please do not send the information electronically, and instead contact Tenex Health, Inc. using the “Contact Tenex Health, Inc.” feature below.
Individual results will vary. The information provided in this site is not meant to substitute for a consultation you should have with your doctor.
References:
- Kim S, et al. Vasc Spec Int 2018;34:109-116.
- Geraghty T, LaPorta G. Expert Rev Pharmacoecon Outcomes Res 2019 Jun;19(3):279-286.
- Armstrong DG, et al. N Engl J Med 2017; 376:2367-2375.
- Freed L. Diabetes 2020 Jun;69(Supplement 1).*
- Data from independent case review. Tenex Health, MKT-392 REV A. Data on file.
*Studies were the independent work of the participating physicians and were not promoted by Tenex Health, Inc. in any way. Tenex Health, Inc. does not promote use of the TX1 MicroTip or TX2 MicroTip for the treatment of hard tissue pathology or diabetic foot ulcers. The TX-Bone (TXB) MicroTip was developed, indicated, and FDA cleared for the treatment of hard tissue pathology and diabetic foot ulcers.